ABSTRACT
Objectives: Neurite outgrowth of neurons is essential for forming functional neural circuits. It is believed that neuronal neurite outgrowth is an important mechanism of brain plasticity. Rosuvastatin (RSV) is a relatively new statin and may have neuroprotective properties. However, whether RSV exerts an effect on neurite extension and its potential mechanism in cortical neurons remains poorly documented. Methods: Immunofluorescence method was used to examine the effect of RSV on neurite outgrowth in primary cortical neuron by measuring neurite length and confirmed the promotion effect. Then, the potential mechanisms involving the Notch1 pathway were investigated. Effects of RSV on the expression of Notch 1 and Hes1were determined using qRT-PCR. In addition, brain-derived neurotrophic factor (BDNF) expression was also assessed using qRT-PCR, and ELISA. Results: RSV promoted neurite outgrowth of cortical neurons, and this effect could be partially prevented by the Notch 1 pathway inhibitor, DAPT. Subsequently, we found that Jagged 1 and Notch 1 were colocalized. In addition, we observed that the levels of both Notch 1 and Hes 1 in cortical neurons were increased after RSV, but sharply decreased after DAPT treatment. Moreover, RSV increased brain-derived neurotrophic factor (BDNF) levels in cortical neurons, but in the culture medium, and the effect could be partially suppressed by DAPT treatment. Discussion: These findings indicate that RSV mediates neurite outgrowth in primary cortical neurons. The RSV-induced neuritogenic effect is mediated at least partly via the Notch1/BDNF pathway.
Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Cerebral Cortex/cytology , Neurites/drug effects , Neuronal Outgrowth/drug effects , Receptor, Notch1/metabolism , Rosuvastatin Calcium/pharmacology , Signal Transduction/drug effects , Animals , Cerebral Cortex/metabolism , Dipeptides/pharmacology , Jagged-1 Protein/metabolism , Mice , Neurites/physiology , Neuronal Outgrowth/physiology , Primary Cell Culture , Receptor, Notch1/biosynthesis , Rosuvastatin Calcium/antagonists & inhibitorsABSTRACT
This study describes the total disposition profiling of rosuvastatin (RSV) and pitavastatin (PTV) using a single systematic procedure called D-PREX (Disposition Profile Exploration) in sandwich-cultured human hepatocytes (SCHH). The biliary excretion fractions of both statins were clearly observed, which were significantly decreased dependent on the concentration of Ko143, an inhibitor for breast cancer resistance protein (BCRP). Ko143 also decreased the basolateral efflux fraction of RSV, whereas that of PTV was not significantly affected. To understand these phenomena, effects of Ko143 on biliary excretion (BCRP and multidrug resistance-associated protein (MRP) 2) and basolateral efflux (MRP3 and MRP4) transporters were examined using transporter-expressing membrane vesicles. BCRP, MRP3 and MRP4-mediated transport of RSV was observed, and Ko143 inhibited these transporters except MRP3. BCRP and MRP4 also mediated the transport of PTV, but the Ko143-mediated inhibition was only clear for BCRP. These results might explain the Ko143-mediated complete and partial inhibition of the biliary excretion and the basolateral efflux of RSV, respectively, in SCHH. In conclusion, D-PREX with sequential sampling of supernatants prior to cell lysis enables the evaluation of total drug disposition profiles resulting from complex interplays of intracellular pathways, which would provide high-throughput evaluation of drug disposition during drug discovery.
